“Serious adverse reactions could occur in patients with a sulfite allergy who are exposed to hydromorphone containing sulfites,” the company said in its recall notice.
The affected product is 0.5 mg/mL hydromorphone HCl in 0.9 percent sodium chloride 1 mL in 3 mL BD syringe.
PharMEDium said it has notified its customers and arranged replacement orders.
More articles on pharmacy:
Walmart cutting some pharmacy jobs
UPMC acquires community pharmacy in Pittsburgh
Oklahoma judge approves Teva’s $85M opioid settlement
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
